Global presence

Canada

Galderma Canada Inc. was established in 1989 as part of a global organization, Galderma S.A. We market prescription products, over-the-counter skin care and aesthetics solutions within Canada to a range of healthcare professionals, including Dermatologists, General Practitioners, Nurses, Pharmacists, Paediatricians and Plastic Surgeons.

Canada page group products

 

Our Products

Our product portfolio includes prescription drugs, medical dermatology and aesthetics, along with therapeutic skin care products aimed at treating skin diseases with a particular focus on acne, rosacea, psoriasis and steroid-responsive dermatoses, skin cancer, and aging skin.

Prescription Products:

Apprilon, Apprilon French PM

Clobex Spray, Clobex Spray French PM

Clobex Shampoo, Clobex Shampoo French PM

Differin/XP, Differin French PM

MetroGel, Metrogel French PM

Metvix, Metvix French PM

Onreltea, Onreltea French PM

Silkis, Silkis French PM

TactuPump Forte / TactuPump, TactuPump / TactuPump FORTE French PM

Rosiver, Rosiver French PM

Benzac Wash 10%

 

Consumer Care Products:

Cetaphil

Cetaphil Baby

 

Aesthetics Products:

Dysport AestheticDysport Aesthetic French PM

Restylane

Restylane Skinboosters

Sculptra

 

Manufacturing Plant – Baie-D’Urfé, QC

Since its inauguration in 2000, the Montreal plant has been sharing its passion for dermatology through the manufacturing of products geared towards improving people’s quality of life.

Located in Baie-D’Urfé (on the western tip of the Island of Montreal), the facility is considered to be Galderma’s main manufacturing plant in North America servicing clients worldwide.

 

Working together

At Galderma, our employees and management work side by side to manufacture products that meet the highest standards in the industry. Management values employee initiatives and accountability, all while ensuring a positive working environment.

 

Growing together

Recognized as a performing and competitive manufacturing site, our Montreal plant has been growing since its inception. This growth is directly attributed to the quality of our products and the expertise of our professionals. Our employees have crafted our success and we support their professional development.

 

A site in full expansion

In 2013 Galderma finalized phase I of its investment funding plan infusing $53 million to expand its infrastructure and acquire equipment in order to meet the growing demand for its products, thus increasing the capacity of the Montreal plant to 95 million units per year. The company’s business plan between now and 2020 projects 120 million units per year to keep up with international market demand. As such, continuous investments will be made in the years to come.

 

Certifications

  • U.S Food and Drug Administration (FDA)

  • Health Canada

  • ISO 14001 environmental management certification

  • OHSAS 18001 certification for occupational health and safety management

  • C-TPAT (Customs-Trade Partnership Against Terrorism) concerning the protection of manufactured goods entering the United States from terrorist security threats.

 

Cetaphil : www.cetaphil.ca

Cetaphil Baby : www.cetaphilbaby.ca

Dysport : https://www.dysportcanada.ca/consumer/

Restylane : https://www.restylane.com/ca/ca-en

Sculpra : http://www.sculptra.ca/

Galderma Connexion : http://galdermaconnexion.ca/user

 

Galderma Canada Inc (Head Office)

55 Commerce Valley Drive W, Suite 400, Thornhill, ON, L3T 7V9

905-762-2500 or 1-800-467-2081

Medical Information: [email protected]

 

Pharmacovigilance: [email protected]

 

Galderma Production Inc. (Baie-D’Urfé, QC)

19400 TransCanada Highway,

Baie-D'Urfé (Quebec) H9X 3S4

Telephone: 514-457-3366